Purohit, A <br/><br/>
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Nov 1998 
 - 119-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0169-5002 
<br/><br/><label>Standard No.: </label>10.1016/s0169-5002(98)00072-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Pleural Neoplasms--drug therapy<br/>Recombinant Proteins